tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders StocksTop Gainers/ Losers/ Active StocksMost Visited WebsitesDividend StocksAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by Upside
New
Top ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
New
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Pro Newsletters
Smart Investor
Popular
Research Tools
Stock ScreenerETF Screener
Popular
Trending StocksDaily Analyst RatingsCompare StocksCompare ETFsPenny Stock ScreenerTechnical Analysis ScreenerDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Education
Personal FinanceHow To Use TipRanksTipRanks LabsWebinar CenterGlossaryFAQs
About Us
About TipRanksContact UsCareersReviewsMobile APP
Working with TipRanks
Enterprise SolutionsTop Online BrokersBecome an Affiliate
Follow Us
NewsTrendingPortfolio
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Notification Center
Top ETFs
Top Smart Score Stocks
Popular
Earnings
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
Plans & Pricing
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders Stocks
Top Gainers/ Losers/ Active Stocks
Most Visited Websites
Dividend Stocks
AI Stocks
Largest Companies by Market Cap
ETFs
ETF Center
Top ETFs by Upside
New
Top ETFs by Smart Score
Top Gainers/ Losers/ Active ETFs
Options
Options Market Overview
Unusual Options Activity
Popular
Most Active Options
Options Volume Leaders
Commodities
Gold
New
Crypto
Crypto Center
Bitcoin
Popular
Ethereum
Currency
Currency Center
EUR/USD
Pro Newsletters
Smart Investor
Popular
Research Tools
Stock Screener
ETF Screener
Popular
Trending Stocks
Daily Analyst Ratings
Compare Stocks
Compare ETFs
Penny Stock Screener
Technical Analysis Screener
Daily Insider Trading Tracker
Calendars
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Economic Indicators
Economic Indicators Center
Inflation Rate
Unemployment Rate
Federal Funds Rate
Calculators
Dividend Calculator
Dividend Yield Calculator
Options Profit Calculator
Dollar Cost Averaging
New
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
News
Portfolio
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Calculators
Compound Interest Calculator
New
Mortgage Calculator
Popular
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Enterprise Solutions
Education
How To Use TipRanks
TipRanks Labs
Webinar Center
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
Follow Us

THAR Stock Latest News

Tharimmune Expands Immunology Pipeline with Intract License
Company AnnouncementsTharimmune Expands Immunology Pipeline with Intract License
4d ago
8K
THAR
Tharimmune acquires global license, partners with Intract Pharma
PremiumThe Fly
Tharimmune acquires global license, partners with Intract Pharma
4d ago
THAR
Tharimmune appoints David Jones to Scientific Advisory Board
PremiumThe Fly
Tharimmune appoints David Jones to Scientific Advisory Board
2M ago
THAR
Tharimmune appoints David Clarke as strategic advisor
PremiumThe Fly
Tharimmune appoints David Clarke as strategic advisor
2M ago
THAR
Tharimmune launches new website amid continuing discussions wtih FDA
PremiumThe Fly
Tharimmune launches new website amid continuing discussions wtih FDA
2M ago
THAR
Tharimmune files to sell 1.01M shares of common stock for holders
PremiumThe FlyTharimmune files to sell 1.01M shares of common stock for holders
2M ago
THAR
Tharimmune appoints Jules Haimovitz as strategic advisor
Premium
The Fly
Tharimmune appoints Jules Haimovitz as strategic advisor
2M ago
THAR
Tharimmune to sell 659,545 shares at $3.16 in private placement
Premium
The Fly
Tharimmune to sell 659,545 shares at $3.16 in private placement
3M ago
THAR
Tharimmune announces Type C meeting with FDA for Phase 2 TH104 program
PremiumThe Fly
Tharimmune announces Type C meeting with FDA for Phase 2 TH104 program
3M ago
THAR
Tharimmune announces results of Phase 1 trial of TH104
PremiumThe Fly
Tharimmune announces results of Phase 1 trial of TH104
3M ago
THAR
Tharimmune Inc trading halted, news pending
PremiumThe Fly
Tharimmune Inc trading halted, news pending
4M ago
THAR
Tharimmune announces 1-for-15 reverse stock split
PremiumThe Fly
Tharimmune announces 1-for-15 reverse stock split
4M ago
THAR
Tharimmune enters option agreement with Washington University
PremiumThe FlyTharimmune enters option agreement with Washington University
5M ago
THAR
Tharimmune establishes Scientific Advisory Board
Premium
The Fly
Tharimmune establishes Scientific Advisory Board
5M ago
THAR
Tharimmune’s Active Common Stock Shares Update
Premium
Company Announcements
Tharimmune’s Active Common Stock Shares Update
7M ago
8K
THAR
Tharimmune doses first patient in Phase 1 trial of TH104
PremiumThe Fly
Tharimmune doses first patient in Phase 1 trial of TH104
8M ago
THAR
Tharimmune provides update on TH-3215, TH-1940 non clinical-stage programs
PremiumThe Fly
Tharimmune provides update on TH-3215, TH-1940 non clinical-stage programs
8M ago
THAR
Tharimmune provides update on TH104 clinical-stage program
PremiumThe Fly
Tharimmune provides update on TH104 clinical-stage program
8M ago
THAR
Tharimmune initiates Phase 1 trial of TH104
PremiumThe Fly
Tharimmune initiates Phase 1 trial of TH104
8M ago
THAR
Tharimmune announces topline phase 1 data with TH104
PremiumThe FlyTharimmune announces topline phase 1 data with TH104
9M ago
THAR
Tharimmune prices $10M public offering at $1.00 per share
Premium
The Fly
Tharimmune prices $10M public offering at $1.00 per share
10M ago
THAR
Tharimmune Inc trading halted, news pending
Premium
The Fly
Tharimmune Inc trading halted, news pending
10M ago
THAR

Trending

Name
Price
Price Change
SPX
S&P 500
DJIA
Dow Jones
NDX
Nasdaq 100
More Trending Stocks >